Analysis: India cancer ruling opens door for cheaper drugs
2012/03/13 06:45:50 @Reuters: World News
MUMBAI (Reuters) - India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say. [ VIEW FULL COVERAGE @Reuters: World News ]  |